nih

Congress has passed a budget for FY 2017 that largely continues support for federal innovation programs and R&D investments. Among the highlights are $17 million for Regional Innovation Strategies (a $2 million increase over FY 2016), level funding of $130 million for the Hollings Manufacturing Extension Partnership and $5 million for SBA’s clusters program. In reviewing dozens of line items, offices that had received significant cuts in the White House’s skinny budget appear to receive some of the largest funding increases (such as the Appalachian Regional Commission, Community Development Block Grant and ARPA-E). However, with the exception of multi-billion dollar increases for Department of Defense R&D, many increases are rather small in terms of overall dollars. This is, at least in part, a reflection of non-defense spending caps rising by only $40 million for FY 2017, limiting the availability of new funds. In this context, science and innovation gains are particularly impressive, with a five percent overall increase for federal R&D that particularly benefits NASA and NIH.

Although the U.S. National Institutes of Health may face decreased funding under the new presidential administration, recently published research in Science argues that public investments in biomedical research play an important role in driving private sector R&D. In an analysis of 365,380 grants awarded by the U.S.

With the visionary language of large federal initiatives like the “Cancer Moonshot” or provocative branding such as “NIH…Turning Discovery into Health®” and the National Institute of Health website further touting “revolutionary ideas often come from unexpected directions,” one might assume an equally ambitious approach is being taken to ensure federal life sciences research is going toward research with the most promise for positive impact and scientific a

Despite increasing demand for life sciences research funding and larger budgets from Congress, access to the investigator research funding from the National Institutes of Health (NIH) is getting harder, according to data released May 31 by Michael Lauer, NIH deputy director for Extramural Research.  R01 grants, the oldest and predominant funding mechanism NIH uses to distribute project-specific research grants, are becoming larger in size and more exclusive in who receives the grants.

The National Institutes of Health (NIH) released a request for information (RFI) that invites comments and suggestions from the public to help in the development of its new five-year strategic plan.

The National Institutes of Health (NIH) announced its first round of investments totaling $46 million under the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. The $46 million will support more than 100 investigator-led research projects in 15 states and several countries to support the development of new tools and technologies to understand neural circuit function and capture a dynamic view of the brain in action.

A pilot collaboration between the National Science Foundation (NSF) Innovation Corps (I-Corps™) and the National Institutes of Health (NIH) will offer a nine-week boot camp to help biomedical researchers bring their discoveries to market. Academic researchers and entrepreneurs who have received SBIR/STTR Phase One awards from participating NIH institutes may apply to the I-Corps at NIH™ for training in building scalable business models around their technologies.

National Institute of Health (NIH) Director Francis S. Collins has accepted recommendations from an NIH working group that call for increased investment in the federal government’s effort to map and understand the human brain. Under the recommended plan, the initiative would receive $400 million each year between 2016-20, which would grow to $500 million a year for 2021-25. The BRAIN Initiative is a multi-agency effort, supported by NIH, Defense Advanced Research Projects Agency of the U.S. Department of Defense, National Science Foundation and Food and Drug Administration.

The National Institutes of Health (NIH) is accepting applications for the Research Evaluation and Commercialization Hub (REACH) program to support proof-of-concept centers (Hubs) that facilitate and accelerate the translation of biomedical innovations into commercial products that improve patient care and enhance health. NIH intends to award approximately $9 million to institutions of higher education to establish three new REACH Hubs.